Addressing “the three Rs”

摘要

In recent years, the advantages anticipatednfrom miniaturization have driven the developmentnof microfluidic technologies, oftennfocused on high-throughput screening.nHowever, screening is not the only step inndrug discovery where there’s been a dramaticnrise in the need to maximize informationnfrom small samples and handlencomplex analytical problems in highnnumbers.